Related Experiment Videos
Reticulum cell sarcoma in azathioprine-treated systemic lupus erythematosus
Annals of the Rheumatic Diseases
|February 1, 1979
Abstract:
The development of a reticulum cell sarcoma in the lung of a patient with systemic lupus erythematosus treated with azathioprine for 18 months is described. This possible hazard of immunosuppressive therapy is discussed in relation to patients with SLE.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Minocycline-induced arthritis.
Clinical and experimental rheumatology·1998
Therapeutic advances in systemic lupus erythematosus.
Current opinion in rheumatology·1998
Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.
Annals of the rheumatic diseases·2026
Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.
Annals of the rheumatic diseases·2026
Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis.
Annals of the rheumatic diseases·2026
Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases.
Annals of the rheumatic diseases·2026
Development of 2‑Methyl-5-phenylpyrrolidine-Based ST2 Inhibitors for Neuroinflammatory Conditions.
ACS medicinal chemistry letters·2026
Abatacept Reduces CD319+ (SLAMF7) Cytotoxic T Cells and Cytokine Production in Systemic Sclerosis.
Arthritis & rheumatology (Hoboken, N.J.)·2026